Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 4 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready
Scai Therapeutics Co. Ltd. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 distinct examiners and 4 distinct art units. The examiner count exceeds the art-unit count, indicating that at least one art unit includes matters assigned to more than one examiner.
BAEK, BONG-SOOK is the busiest examiner, with 2 pending matters. This creates a limited point of examiner continuity within a broader distribution of assignments, while the remaining matters require separate review.
The portfolio should be managed through both art-unit organization and examiner-specific preparation. The available data does not establish whether the matters share claim language, disclosure, or substantive examination issues.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, BONG-SOOK | 2 | 41.6% | +69.9% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| KAMM, JUDITH MARIE | 1 | 42.9% | +57.1% |
| WORSHAM, JESSICA N | 1 | 56.6% | +56.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838123 | HIGH-MOLECULAR-WEIGHT HYALURONIC ACID STRUCTURE, METHOD FOR PREPARING SAME, AND OPHTHALMIC COMPOSITION INCLUDING SAME | BERRY, LAYLA D | — |
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18423812 | AMORPHOUS NANO-MOLECULAR AGGREGATE COMPOSED OF ORGANIC MATERIAL, INORGANIC MATERIAL, OR SALT THEREOF, AND METHOD FOR PREPARING SAME | KAMM, JUDITH MARIE | 33d |
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18421490 | NANO-MOLECULE AGGREGATE CONSISTING OF ORGANIC MATERIAL, INORGANIC MATERIAL OR SALT THEREOF AND PREPARATION METHOD THEREFOR | WORSHAM, JESSICA N | — |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | — |
| 18579262 | MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT | BAEK, BONG-SOOK | — |
| Art Unit | Apps |
|---|---|
| 1693 | 2 |
| 1611 | 2 |
| 1616 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838123 | HIGH-MOLECULAR-WEIGHT HYALURONIC ACID STRUCTURE, METHOD FOR PREPARING SAME, AND OPHTHALMIC COMPOSITION INCLUDING SAME | BERRY, LAYLA D | 1693 | §102§103§112Other | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §101§102§103§112DP | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18423812 | AMORPHOUS NANO-MOLECULAR AGGREGATE COMPOSED OF ORGANIC MATERIAL, INORGANIC MATERIAL, OR SALT THEREOF, AND METHOD FOR PREPARING SAME | KAMM, JUDITH MARIE | 1611 | §103Other | Final Rejection | 33d | Pending | Jan 26, 2024 |
| 18421490 | NANO-MOLECULE AGGREGATE CONSISTING OF ORGANIC MATERIAL, INORGANIC MATERIAL OR SALT THEREOF AND PREPARATION METHOD THEREFOR | WORSHAM, JESSICA N | 1615 | §102§112DP | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | 1611 | §102§103§112 | Final Rejection | — | Pending | Jan 12, 2024 |
| 18579262 | MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT | BAEK, BONG-SOOK | 1693 | §102§103§112DP | Non-Final OA | — | Pending | Jan 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialScai Therapeutics Co. Ltd. has 6 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Bong-Sook Baek has the most, with 2 of Scai Therapeutics Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
